Literature DB >> 11745773

Controlling deamidation rates in a model peptide: effects of temperature, peptide concentration, and additives.

L P Stratton1, R M Kelly, J Rowe, J E Shively, D D Smith, J F Carpenter, M C Manning.   

Abstract

The rate of deamidation of the Asn residue in Val-Tyr-Pro-Asn-Gly-Ala (VYPNGA), a model peptide, was determined at pH 9 (400 mM Tris buffer) as a function of temperature and peptide concentration. Over the temperature range 5-65 degrees C, deamidation followed Arrhenius behavior, with an apparent activation energy of 13.3 kcal/mol. Furthermore, increasing the peptide concentration slows the rate of deamidation. Self-stabilization with respect to deamidation has not been reported previously. The rate of deamidation was also determined in the presence of sucrose and poloxamer 407 (Pluronic F127). In both cases, the rate of deamidation was retarded by up to 40% at 35 degrees C. In aqueous solutions containing poloxamer 407, the degree of stabilization is independent of formation of a reversible thermosetting gel. With sucrose, maximum reduction in the deamidation rate was attained with as little as 5% (w/v). Addition of sucrose results in a greater conformational preference for a type II beta-turn structure, which presumably is less prone to intramolecular cyclization and subsequent deamidation. Copyright 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745773     DOI: 10.1002/jps.1165

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Characterization of recombinant human IL-15 deamidation and its practical elimination through substitution of asparagine 77.

Authors:  David F Nellis; Dennis F Michiel; Man-Shiow Jiang; Dominic Esposito; Richard Davis; Hengguang Jiang; Angela Korrell; George C Knapp; Lauren E Lucernoni; Roy E Nelson; Emily M Pritt; Lauren V Procter; Mark Rogers; Terry L Sumpter; Vinay V Vyas; Timothy J Waybright; Xiaoyi Yang; Amy M Zheng; Jason L Yovandich; John A Gilly; George Mitra; Jianwei Zhu
Journal:  Pharm Res       Date:  2011-10-19       Impact factor: 4.200

2.  Long-term stability and in vitro release of hPTH(1-34) from a multi-reservoir array.

Authors:  Elizabeth R Proos; James H Prescott; Mark A Staples
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

Review 3.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

4.  Coping with cold: the genome of the versatile marine Antarctica bacterium Pseudoalteromonas haloplanktis TAC125.

Authors:  Claudine Médigue; Evelyne Krin; Géraldine Pascal; Valérie Barbe; Andreas Bernsel; Philippe N Bertin; Frankie Cheung; Stéphane Cruveiller; Salvino D'Amico; Angela Duilio; Gang Fang; Georges Feller; Christine Ho; Sophie Mangenot; Gennaro Marino; Johan Nilsson; Ermenegilda Parrilli; Eduardo P C Rocha; Zoé Rouy; Agnieszka Sekowska; Maria Luisa Tutino; David Vallenet; Gunnar von Heijne; Antoine Danchin
Journal:  Genome Res       Date:  2005-09-16       Impact factor: 9.043

Review 5.  Non-Arrhenius protein aggregation.

Authors:  Wei Wang; Christopher J Roberts
Journal:  AAPS J       Date:  2013-04-25       Impact factor: 4.009

6.  Deamidation of Human γS-Crystallin Increases Attractive Protein Interactions: Implications for Cataract.

Authors:  Ajay Pande; Natalya Mokhor; Jayanti Pande
Journal:  Biochemistry       Date:  2015-07-29       Impact factor: 3.162

7.  Biochemical Characterization of Human Anti-Hepatitis B Monoclonal Antibody Produced in the Microalgae Phaeodactylum tricornutum.

Authors:  Gaëtan Vanier; Franziska Hempel; Philippe Chan; Michael Rodamer; David Vaudry; Uwe G Maier; Patrice Lerouge; Muriel Bardor
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

8.  Development of an LC-MS/MS peptide mapping protocol for the NISTmAb.

Authors:  Trina Mouchahoir; John E Schiel
Journal:  Anal Bioanal Chem       Date:  2018-02-07       Impact factor: 4.142

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.